Ownership Summary
A total of 7 institutions have reported a stake in Northwest Biotherapeutics Inc (OTC:NWBO) as of September 2025, according to recent 13F filings with the SEC.
- These investors collectively held 0.0% of the company's total shares outstanding in September 2025, down from 0.0% in June 2025.
- The company experienced a -11.11% quarterly change in institutional shares held, alongside a decrease of 12.50% in total owners annually.
- A review of institutional activity for Northwest Biotherapeutics shows 0 of 7 filers increasing their positions, while 1 reduced their stake, and 6 remained unchanged.
- This class of investors decreased its holdings in Northwest Biotherapeutics to 189.59K shares for the 13F-cycle ending September 2025, down by 23.70K shares quarter on quarter, and up 25.22K shares year over year.
- The top institutional stake in Northwest Biotherapeutics as of September 30, 2025 belongs to VSM Wealth Advisory, LLC, which owns 65.57K shares, or 0.00% of the company.
- Leading sellers of Northwest Biotherapeutics stock in September 2025 included Ethos Financial Group, LLC (23.70K).
- The top 7 institutional holders of Northwest Biotherapeutics for the quarter ending September 2025 included VSM Wealth Advisory, LLC (65.57K), Opus Capital Group, LLC (60.15K), Williams Jones Wealth Management, LLC. (27.00K), Ethos Financial Group, LLC (25.35K), ADVISORS MANAGEMENT GROUP INC /ADV (10.27K), Coston, McIsaac & Partners (1.00K), HANTZ FINANCIAL SERVICES, INC. (250).